Shop Research About Compliance Affiliate Free Consultation
HOT

Retatrutide + Cagrilintide

Reta-Cagri · Triple Agonist + Amylin Combination

Pre-mixed research blend combining retatrutide (GLP-1/GIP/glucagon triple agonist) with cagrilintide (amylin analog). Quadruple-pathway metabolic research.

✓ HPLC Verified ✓ 99%+ Purity ✓ COA Available ✓ Manufacturer Direct ✓ Direct Support
📋 Certificate of Analysis Request COA via Telegram
Select Size
per vial
+ $40 shipping · Free over $1,000 · ~2 week delivery
✓ Added to cart View Cart →
Research Data

What Is Retatrutide + Cagrilintide?

This blend combines retatrutide's triple agonism (GLP-1, GIP, glucagon) with cagrilintide's amylin receptor activity, creating a four-receptor pathway model. Research interest focuses on maximizing metabolic impact across satiety, energy expenditure, and hepatic fat pathways.

Research Context

  • Four-receptor pathway: GLP-1, GIP, GCG, amylin
  • Energy expenditure amplification via glucagon component
  • Hypothalamic satiety convergence model
  • Combination approach beyond current approved agents

Storage & Reconstitution

Store lyophilized at -20°C. Reconstitute with bacteriostatic water. Use within 28 days at 2–8°C.

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.